A clinical-grade constitutive packaging cell line for the production of self-inactivating lentiviral vectors

被引：0
|
作者：
Knight, Sean [1 ,2 ]
Sanber, Khaled [1 ,2 ]
Stephen, Sam [1 ,2 ]
Ferraresso, Marta [1 ,2 ]
Baley, Ranbir [1 ,2 ]
Escors, David [1 ,2 ]
Santilli, Giorgia [3 ]
Thrasher, Adrian [3 ]
Collins, Mary [1 ,2 ]
Takeuchi, Yasu [1 ,2 ]
机构：
[1] UCL, UCL Canc Inst, MRC UCL Ctr Med Mol Virol, London, England
[2] UCL, UCL Canc Inst, Wohl Virion Ctr, Div Infect & Immun, London, England
[3] UCL, Inst Child Hlth, Mol Immunol Unit, Ctr Immunodeficiency, London, England
来源：
HUMAN GENE THERAPY | 2014年 / 25卷 / 11期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
P142
引用
收藏
页码：A101 / A102
页数：2
相关论文
共 50 条
  • [31] Self-inactivating lentiviral vectors with U3 and U5 modifications
    Iwakuma, T
    Cui, Y
    Chang, LJ
    VIROLOGY, 1999, 261 (01) : 120 - 132
  • [32] SELF-INACTIVATING LENTIVIRAL VECTORS FOR CORRECTION OF RAG1 SEVERE COMBINED IMMUNODEFICIENCY
    Pike-Overzet, Karin
    Rodijk, Mark
    Ng, Yuk Yin
    Baert, Miranda
    Lagresle-Peyrou, Chantal
    Schambach, Axel
    Zhang, Fang
    Hoeben, Rob
    Hacein-Bey-Abina, Salima
    Lankester, Arjan
    Bredius, Robbert
    Driessen, Gertjan
    Thrasher, Adrian
    Baum, Christopher
    Cavazzana-Calvo, Marina
    van Dongen, Jacques
    Staal, Frank
    EXPERIMENTAL HEMATOLOGY, 2012, 40 (08) : S46 - S47
  • [33] Shedding of clinical-grade lentiviral vectors is not detected in a gene therapy setting
    Cesani, M.
    Plati, T.
    Lorioli, L.
    Benedicenti, F.
    Redaelli, D.
    Dionisio, F.
    Biasco, L.
    Montini, E.
    Naldini, L.
    Biffi, A.
    GENE THERAPY, 2015, 22 (06) : 496 - 502
  • [34] Shedding of clinical-grade lentiviral vectors is not detected in a gene therapy setting
    M Cesani
    T Plati
    L Lorioli
    F Benedicenti
    D Redaelli
    F Dionisio
    L Biasco
    E Montini
    L Naldini
    A Biffi
    Gene Therapy, 2015, 22 : 496 - 502
  • [35] Systemic injection in a tumor prone mouse unravels the residual genotoxicity of self-inactivating lentiviral vectors
    Cesana, D.
    Ranzani, M.
    Bartholomae, C.
    Volpin, M.
    Benedicenti, F.
    VonKalle, C.
    Schmidt, M.
    Naldini, L.
    Montini, E.
    HUMAN GENE THERAPY, 2010, 21 (10) : 1484 - 1484
  • [36] Critical Variables affecting clinical-grade production of the self-inactivating gamma-retroviral vector for the treatment of X-linked severe combined immunodeficiency
    van der Loo, J. C. M.
    Swaney, W. P.
    Grassman, E.
    Terwilliger, A.
    Higashimoto, T.
    Schambach, A.
    Hacein-Bey-Abina, S.
    Nordling, D. L.
    Cavazzana-Calvo, M.
    Thrasher, A. J.
    Williams, D. A.
    Reeves, L.
    Malik, P.
    GENE THERAPY, 2012, 19 (08) : 872 - 876
  • [37] Critical Variables affecting clinical-grade production of the self-inactivating gamma-retroviral vector for the treatment of X-linked severe combined immunodeficiency
    J C M van der Loo
    W P Swaney
    E Grassman
    A Terwilliger
    T Higashimoto
    A Schambach
    S Hacein-Bey-Abina
    D L Nordling
    M Cavazzana-Calvo
    A J Thrasher
    D A Williams
    L Reeves
    P Malik
    Gene Therapy, 2012, 19 : 872 - 876
  • [38] Self-inactivating helper virus for the production of high-capacity adenoviral vectors
    M Gonzalez-Aparicio
    I Mauleon
    P Alzuguren
    M Bunuales
    G Gonzalez-Aseguinolaza
    C San Martín
    J Prieto
    R Hernandez-Alcoceba
    Gene Therapy, 2011, 18 : 1025 - 1033
  • [39] Self-inactivating helper virus for the production of high-capacity adenoviral vectors
    Gonzalez-Aparicio, M.
    Mauleon, I.
    Alzuguren, P.
    Bunuales, M.
    Gonzalez-Aseguinolaza, G.
    San Martin, C.
    Prieto, J.
    Hernandez-Alcoceba, R.
    GENE THERAPY, 2011, 18 (11) : 1025 - 1033
  • [40] 3′ Self-Inactivating Long Terminal Repeat Inserts for the Modulation of Transgene Expression from Lentiviral Vectors
    Manic, Gwenola
    Maurin-Marlin, Aurelie
    Galluzzi, Lorenzo
    Subra, Frederic
    Mouscadet, Jean-Francois
    Bury-Mone, Stephanie
    HUMAN GENE THERAPY METHODS, 2012, 23 (02) : 84 - 97
12345